Skip to main content

Table 1 Presence of regulatory cells (T cells [FOXP3 + , CTLA-4 + ], MDSCs [Monocytic, Granulocytic]) in women with LLABCs

From: Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC

Nature of Regulatory Cells

% in the Circulation of Women with LLABCs* (n = 31)

% in the Circulation of HFDs** (n = 10)

AbN (cells/μl) in the Circulation of Women with LLABCs* (n = 25)

AbN (cells/μl) in the Circulation of HFDs (n = 10)

T regulatory: % (CD4+ CD25+ CD127- FOXP3+); AbN (CD4+ CD25+)

1.64 ± 0.36*** (7 fold increase)

0.24 ± 0.02

201.33 ± 13.33 (6 fold increase)

35.71 ± 2.71

T regulatory: % (CD4+ CD25+ CD152+); AbN (CD4+ CD25+ CD152+)

1.43 ± 0.08 (7 fold increase)

0.21 ± 0.05

17.00 ± 0.90 (2 fold increase; p = 0.002)

9.75 ± 0.55

MDSCs: AbN monocyte-derived (CD11b+ CD14+ HLA DR- CD124+ CD33+)

-

-

28.67 ± 4.33 (3 fold increase)

10.20 ± 2.80

MDSCs: AbN granulocyte-derived (CD11b+ CD14- CD66b+ CD124+ CD15+)

-

-

185.13 ± 14.86 (1.5 fold increase; p = 0.025)

129.00 ± 21.00

  1. * LLABCs: Large and locally advanced breast cancers; ** HFDs: Healthy female donors; ***: Values shown for patients with LLABCs and HFDs are Means ± SDs.